Voleon Capital Management LP Takes $2.08 Million Position in Humana Inc. $HUM

Key Points

• Voleon Capital Management LP purchased 7,852 shares of Humana Inc., valued at approximately $2,078,000, indicating growing interest in the healthcare provider.
• Institutional investors now hold 92.38% of Humana's stock, with several firms increasing their stakes significantly during the first quarter.
• Humana announced a quarterly dividend of $0.885 per share, equating to a 1.1% yield, reinforcing its commitment to returning value to shareholders.

Voleon Capital Management LP purchased a new stake in Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 7,852 shares of the insurance provider's stock, valued at approximately $2,078,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UniSuper Management Pty Ltd boosted its position in Humana by 4.8% in the first quarter. UniSuper Management Pty Ltd now owns 11,770 shares of the insurance provider's stock valued at $3,114,000 after buying an additional 543 shares in the last quarter. Permanens Capital L.P. boosted its position in Humana by 32.5% in the first quarter. Permanens Capital L.P. now owns 2,790 shares of the insurance provider's stock valued at $741,000 after buying an additional 685 shares in the last quarter. Nissay Asset Management Corp Japan ADV boosted its position in Humana by 1.2% in the first quarter. Nissay Asset Management Corp Japan ADV now owns 14,974 shares of the insurance provider's stock valued at $3,962,000 after buying an additional 182 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Humana by 1.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,810 shares of the insurance provider's stock valued at $4,448,000 after buying an additional 299 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its position in Humana by 3.0% in the first quarter. Alliancebernstein L.P. now owns 155,642 shares of the insurance provider's stock valued at $41,183,000 after buying an additional 4,547 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Down 0.8%

Shares of HUM traded down $2.36 on Friday, reaching $276.36. 1,138,341 shares of the company's stock were exchanged, compared to its average volume of 1,648,760. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $33.24 billion, a P/E ratio of 21.21, a price-to-earnings-growth ratio of 1.64 and a beta of 0.44. The business has a 50 day moving average price of $265.34 and a two-hundred day moving average price of $257.18. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $325.75.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio is presently 27.17%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on HUM shares. Royal Bank Of Canada boosted their price target on shares of Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a research report on Thursday, August 21st. Wells Fargo & Company dropped their target price on shares of Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a research note on Thursday, August 14th. Barclays boosted their target price on shares of Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research note on Friday, September 5th. Bank of America boosted their target price on shares of Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research note on Tuesday, September 2nd. Finally, Morgan Stanley dropped their target price on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Seven analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $289.24.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.